Cooley's Anemia Foundation funds clinical trials in cell and gene therapy to advance curative treatments for Thalassemia, supporting essential scientific and trial-related research activities.
The Ongoing Clinical Research in Thalassemia Application funds impactful clinical studies to improve patient care and outcomes for Thalassemia, supported by the Cooley's Anemia Foundation.
The Cooley's Anemia Foundation's Research Fellowship Grant supports early-career scientists conducting innovative research on Thalassemia and its complications.
Academic Clinical Trials Program (ACT) supports academic investigators conducting blood cancer trials to test new treatments, expand existing therapy uses, and improve care for unmet medical needs.
CLIN2 Awards: Funding Opportunity for Clinical Trials supports clinical teams testing stem cell-based or genetic therapies in phase 1, 2, or 3 trials to address serious unmet medical needs.
The Hoffman ALS Clinical Trial Awards Program supports researchers conducting early-stage trials of ALS treatments and imaging tracers to generate safety, dosing, and biomarker data for later development.